Clinical Trials
Corbus Pharmaceuticals Initiates “RESOLVE-1” Phase 3 Study in Systemic Sclerosis
Corbus Pharmaceuticals Holdings, Inc. , a clinical stage drug development company targeting rare, serious chronic inflammatory and fibrotic diseases, announced that it has initiated...
News
Major changes for bio supply forecast in 2018 by bioLIVE
Industry experts from bioLIVE – the new UBM biomanufacturing and bioprocessing event taking place next year in Madrid (October 9-11). Predict...
Drug Research
Idorsia forms research collaboration with Roche in the field of cancer immunotherapy
Idorsia Ltd announced that it has entered into a research collaboration that provides Roche with an exclusive option right to develop and market first-in-class...
Articles
Innovative solutions to improve supply chain efficiency
Do you providecompanies with innovative solutions to improve supply chain efficiency?
In addition to our primary packaging for solid doses, unit dose packaging and secondary...
Press Releases
Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member
Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company announced the appointment of Annalisa Jenkins, MBBS, FRCP, formerly President and CEO...
Articles
FDA enforcement discretion: why delaying serialization implementation is a risky strategy
In June 2017, the FDA announced that it will delay the active enforcement of the Drug Supply Chain Security Act (DSCSA) for pharmaceutical manufacturers...
Press Releases
Singapore Institutes Collaborate with Samsung Medical Center to Improve Treatment of Liver Cancer
Scientists and doctors from Singapore institutes are collaborating with Samsung Medical Center (SMC), a leading academic medical centre in Seoul, Republic of Korea, to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read